ArticleKidney international reports2024

Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis.

Gabriel C Barsotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.